UnitedHealth Raises Outlook Following Strong Q1 Earnings

Photo of Paul Ausick
By Paul Ausick Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
UnitedHealth Raises Outlook Following Strong Q1 Earnings

© Thinkstock

UnitedHealth Group Inc. (NYSE: UNH) reported first-quarter 2016 results before markets opened Tuesday. The health insurance and benefits management firm reported adjusted diluted quarterly earnings per share (EPS) of $1.81 on revenues of $44.53 billion. In the same period a year ago, UnitedHealth reported EPS of $1.55 on $35.76 billion in revenue. Fourth-quarter results also compare to the consensus estimates for EPS of $1.72 on revenues of $35.76 billion.

For 2016, the company forecast revenues of approximately $182 billion and EPS in a range of $7.75 to $7.95. Cash flow from operations was pegged at up to $10 billion. UnitedHealth raised its EPS estimate by $0.15. Consensus full-year estimates called for EPS of $7.73 and revenues of $181.42 billion.

Total enrollment numbers increased year over year from 45.76 million to 47.67 million. Commercial enrollments rose from 29.43 million to 30.43 million. Medicare and Medicaid enrollment rose from 12.18 million to 13.18 million, and international enrollment slipped from 4.16 million to 4.07 million.

The consolidated medical care ratio rose by 0.3% to 81.7% for the quarter.
[nativounit]
UnitedHealth repurchased 4.2 million shares of the company’s common stock for about $500 million in the first quarter at a weighted average price of $119 per share.

In the company’s UnitedHealthcare insurance business, revenues grew $3.3 billion year over year in the quarter and rose $3.1 billion sequentially. Profits were flat year over year and operating margin slipped from 5.8% to 5.2%. The company said the decline in margin was driven by increased quarterly costs from an extra calendar day of service and public exchange performance, partially offset by reserve development.

Shares closed up about 0.4% on Monday, at $127.81 in a 52-week range of $95.00 to $131.10. The stock was up 1% in Tuesday’s premarket session to $129.05. Thomson Reuters had a consensus analyst price target of $142.26 before the results were announced.

Photo of Paul Ausick
About the Author Paul Ausick →

Paul Ausick has been writing for a673b.bigscoots-temp.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.

He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618